Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer

Clinical trial NCT03916419 · COMPLETED

Trial details

NCT number: NCT03916419
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IIB Non-Small Cell Lung Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IIIC Non-Small Cell Lung Cancer

Start date: 2019-06-20
Primary completion: 2025-09-28
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.